Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
Fang Liu(Central South University), Jingping Zhao(Central South University), Rengrong Wu(Central South University), Yingjun Zheng(Central South University), Ye Chun Ruan(Hong Kong Polytechnic University), Bingkui Zhang(Kunming Medical University), Liqin Xie(Sichuan University), Limei Zhang(Yunnan Provincial Infectious Disease Hospital), Li Yang(Hunan Normal University), Shuyun Yang(Baoshan College), Xiaofeng Guo(Central South University), Xiufeng Xu(Kunming Medical University), Jianjun Ou(Central South University), Junwei Yang(Yunnan Provincial Infectious Disease Hospital), Yong Zeng(Huanggang Central Hospital)
Cited by 136
Related Papers
Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats
|Nature Medicine|2016|1k
The path to healthy ageing in China: a Peking University–Lancet Commission
|The Lancet|2022|955
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
|The Lancet Psychiatry|2021|826
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China
|Schizophrenia Research|2015|320
Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic
|Translational Psychiatry|2020|312